IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression.
Xiao P, Meng Q, Liu Q, Lang Q, Yin Z, Li G, Li Z, Xu Y, Yu Z, Geng Q, Zhang Y, Liu L, Xie Y, Li L, Chen H, Pei T, Sun B.
Xiao P, et al.
Cancer Lett. 2023 Mar 31;557:216075. doi: 10.1016/j.canlet.2023.216075. Epub 2023 Feb 1.
Cancer Lett. 2023.
PMID: 36736530